Get access to our best features

Get access to our best features

Published 11 days ago

Tessier-Lavigne leads new AI biopharma startup

Summary by Stanford Daily

Former Stanford President Marc Tessier-Lavigne is now the CEO of a biopharma startup, reported Endpoint News. The company, Xaira, seeks to use artificial intelligence (AI) technology to generate molecules to treat diseases. As of April 23, Xaira already accrued $1 billion in investments. Xaira doesn’t have a website or specific products to promote yet, and information about the company is limited. Tessier-Lavigne stepped down as Stanford’s pres…

0 Articles

0 Articles

All

Left

Center

Right

Tessier-Lavigne leads new AI biopharma startup

Former Stanford President Marc Tessier-Lavigne is now the CEO of a biopharma startup, reported Endpoint News. The company, Xaira, seeks to use artificial intelligence (AI) technology to generate molecules to treat diseases. As of April 23, Xaira already accrued $1 billion in investments. Xaira doesn’t have a website or specific products to promote yet, and information about the company is limited. Tessier-Lavigne stepped down as Stanford’s pres…

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left1Leaning Right0Center0Last Updated10 days agoBias Distribution

100% Left

Bias Distribution

100% of the sources lean Left

100% Left

Stanford Daily

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics

Trending Topics

Donate Privacy Policy Manage Cookies Terms and Conditions

© 2024 Snapwise Inc.